January 29, 2013 Editor 0
Nature Biotechnology 31, 10 (2013).
Author: Linda Nordling
The US National Institutes of Health (NIH) and the London-based charity Wellcome Trust launched a new initiative designed to bolster Africa’s genomics research capacity. The Human Heredity and Health in Africa (H3Africa) scheme announced on October 8 is a $38-million, five-year project aimed at studying diseases that affect the continent’s people.
- Africa Analysis: Donors should focus on national R&D funds
- Persecuting Biotechnology
- Build on genomic advances to benefit the poor
- Biotechnologies at Work for Smallholders: Case Studies from Developing Countries in Crops, Livestock and Fish
- Africa Analysis: Ocean science urgently needs investment
- Crowd-funded micro-grants for genomics and an actionable idea connecting small (artisan) science, infrastructure science, and citizen philanthropy.
Subscribe to our stories
- Giving Francophone African incubators the keys to accelerate growth entrepreneurship February 13, 2018
- Is acceleration the panacea for scaling growth entrepreneurs? Reflections from XL Africa February 13, 2018
- Why providing pre-seed and seed capital is the essential step to bringing West Africa and Sahel’s entrepreneurs to the next level February 13, 2018
- Global Investment Competitiveness: New Insights on FDI February 2, 2018
- BioInnovate Africa phase II launched February 2, 2018